Sera from Hartley guinea pigs vaccinated with a veterinary live spore anthrax vaccine were compared with sera from guinea pigs vaccinated with the human anthrax vaccine, which consists of aluminum hydroxideadsorbed culture proteins of Bacilus anthracis V770-NP-1R. Sera from animals vaccinated with the spore vaccine recognized two major B. anthracis vegetative cell-associated proteins that were either not recognized or poorly recognized by sera from animals that received the human vaccine. These proteins, termed extractable antigens 1 (EA1) and 2 (EA2), have molecular masses of 91 and 62 kilodaltons, respectively. The EAl protein appeared to be coded by chromosomal DNA, whereas the EA2 protein was only detected in strains that possessed the pXO1 toxin plasmid. Both of the extractable antigen proteins were serologically distinct from the components of anthrax edema toxin and lethal toxin. Following vaccination with the live spore vaccine, the EAl protein was the predominant antigen recognized, as determined by electrophoretic immunotransblots. Vaccine trials with partially purified EAl demonstrated that it neither elicits protective antibody against anthrax nor delays time to death in guinea pigs challenged intramuscularly with virulent Ames strain spores. In addition, animals vaccinated with sterile gamma-irradiated cell walls had significant antibody titers to the Nacetylglucosamine-galactose polysaccharide of B. anthracis but were neither protected nor had a delay in time to death following challenge.
Bacillus anthracis, the etiologic agent of anthrax, possesses three virulence factors, a poly-D-glutamic acid capsule, edema toxin, and lethal toxin. Edema toxin is composed of two proteins, edema factor (EF; 89 kilodaltons [kDa] ) and protective antigen (PA; 85 KDa), and likewise, lethal toxin is composed of lethal factor (LF; 82 KDa) and PA (1, 5, 18, 26, 27, 30, 34) . PA plays a central role in that it is required for the transport of EF and LF into host target cells (6, 17, 22) . All three toxin proteins are encoded for by a 110-MDa plasmid, pXO1 (21) , whereas the capsule is encoded for by a 60-MDa plasmid, pXO2 (7, 33) . Strains that lack either or both of the plasmids are avirulent.
In most countries, livestock at risk are immunized annually with commercial vaccines (i.e., Anvax; Wellcome Animal Research Laboratories, Beckenham, England [Div. Burroughs Wellcome Co.]), which are composed of viable spores of B. anthracis Sterne, a nonencapsulated toxigenic variant (pXO1+, pXO2-) which is safe and efficacious in protecting against anthrax (28, 29) . In contrast, the human anthrax vaccine licensed in the United States, which is produced by the Michigan Department of Public Health (MDPH), consists of aluminum hydroxide-adsorbed culture filtrates of the nonencapsulated, toxigenic strain V770-NP-1R (2, 8, 24) and is primarily composed of PA.
Because PA plays such a central role, it is a generally held belief that antibody induced to this protein protects the vaccinee by neutralizing toxin activity. Indeed, this may be partially accurate; however, one cannot discount the reports that humoral antibody titers to PA do not correlate well with protection and that protection in animals vaccinated with live spore vaccines is better and more prolonged than is protection in those vaccinated with chemical vaccines (i.e., MDPH, adsorbed PA) (12, 15, 19) . Little and Knudson (19) have reported that, although titers to PA were higher in * Corresponding author.
animals vaccinated with the MDPH human vaccine as opposed to those vaccinated with B. anthracis Sterne (Anvax) , only animals vaccinated with B. anthracis Sterne were completely protected against vaccine-resistant B. anthracis strains.
In light of the observations presented above, we questioned whether there are proteins other than PA, such as vegetative cell surface antigens, that are antigenic in animals vaccinated with a live spore vaccine but not with the human vaccine. Two such proteins were identified and were designated extractable antigens 1 (EA1) and 2 (EA2). In this report we described the partial purification of EAl and vaccine studies with this protein, which appears to be a highly antigenic major surface protein. Antibody titers to the cell wall polysaccharide of B. anthracis (3, 20) were also quantitated in prechallenged animals to determine whether antibody levels to this N-acetylglucosamine-galactose polymer correlated with protection. (19) . Strains cured of their pXO1 toxin plasmid (designated with the prefix A; see Table 2 ) have also been described (10) . Frozen spore stock suspensions were revived on 5% sheep blood agar by incubating them at 37°C for 18 to 20 h. Growth from blood agar cultures was inoculated into R medium (25) that was buffered with 50 mM Tris hydrochloride (pH 7.5) . The cultures, 500 ml in 2-liter sealed screw-top flasks, were incubated in a New Brunswick Scientific incubator shaker at 100 rpm and 37°C for 18 to 20 h.
Cell extraction. Cells were harvested by centrifugation at 104 x g for 15 min and washed in 100 ml of R medium. The cells were suspended to 0.1 g (wet weight)/ml in sodium dodecyl sulfate (SDS) extraction buffer (13) , which consisted of 5 mM Tris hydrochloride, 1% (wt/vol) SDS, and 5 mM 2-mercaptoethanol (pH 9.8), that was heated to 70°C for 30 min, cooled to ambient temperatures, and centrifuged as described above. The supernatant, which contained extracted proteins, was filtered through a 0.22-,m-pore-size, low protein-binding, cellulose acetate filter (Millipore Corp., Bedford, Mass.).
Culture supernatants were filtered, placed in dialysis tubing (3,500-molecular-weight cutoff), concentrated at 4°C in polyethylene glycol, and reconstituted with 0.1 volumes of extraction buffer. The dialysis bags were resealed and boiled for 1 min to release proteins which may have become bound to the tubing. The samples were transferred to a polypropylene vial, boiled for an additional 4 min, and then stored at -200C.
SDS-polyacrylamide gel electrophoresis. To ensure the saturation of proteins with SDS prior to electrophoresis, the cell extracts and concentrated culture fluids were mixed with 5 x sample buffer to give a final concentration of 1% (wt/vol) SDS, 10% (vol/vol) glycerol, and 10 mM 2-mercaptoethanol and placed in a boiling water bath for 5 min. Samples were electrophoresed on polyacrylamide gels (16) containing 10% (wt/vol) acrylamide (acrylamide-bisacrylamide [37.5:1]; pH 8.8) with 5% acrylamide stacking gels (pH 6.8). Electrophoresis was stopped when the bromphenol blue tracking dye had migrated 10 cm.
Electrophoretic immunotransblot. Following electrophoresis, the proteins were electrophoretically transblotted onto nitrocellulose (Nc) (31) in transblot buffer (20 mM Tris, 150 mM glycine, 20% methanol [pH 8.5] ; before the addition of methanol) for 16 to 18 h at 150 mA. The 10-by 14-cm Nc sheet was then incubated in 100 ml of quench buffer (0.5% gelatin, 30 mM sodium citrate, 5% [wt/vol] nonfat powdered milk, 10 mM HEPES [N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic acid], 100 mM NaCl [pH 7.5]) for 30 min at 37°C. The treated Nc was cut into 2.5-mm-wide strips and placed into disposable incubation trays (Accutran; Schleicher & Schuell, Inc., Keene, N.H.). The strips were occasionally cut the day before use and then stored at -20°C in quench buffer containing 50% glycerol (2 ml per well). The eight-trough incubation trays were washed in a 96-well microtiter plate washer (Skatron Inc., Sterling, Va.; 12 ports in each trough), with one three-cycle wash, by using 10 mM sodium phosphate-buffered saline (PBS; pH 7.3)-0.3% Tween 20 (PBST). Each strip was incubated in 1 ml of antiserum or monoclonal antibody (MAb) that was empirically diluted in PBST-0.5% gelatin (PBSTG) for 2 h at 37°C and then washed with one four-cycle wash in a microtiter plate washer. For detection of mouse MAb, the strips were incubated for 1 h in rabbit anti-mouse immunoglobulin G (IgG), IgA, and IgM (Calbiochem-Behring, La Jolla, Calif.) diluted 1:400 in PBSTG at 37°C. Detection of rabbit antimouse antibody and guinea pig antibody was accomplished by incubating the strips in horseradish peroxidase-protein A conjugate (supplied by Stephen Leppla, U.S. Army Medical Research Institute of Infectious Diseases), diluted 1:5,000 in PBSTG, for 30 min at ambient temperatures. The strips were washed with one five-cycle wash in a microtiter plate washer. Conjugate-antibody complexes were detected by using the chromogenic substrate (4 ml of tetramethylbenzidine [5 KDa), and myosin (200 KDa). The standards were treated with 5x sample buffer as described above, electrophoresed in lanes adjacent to those containing cell extracts, and transblotted; and the Nc was stained with AuroDye (Janssen, Piscataway, N.J.) The electrophoretic mobilities of the standards were calculated and plotted, and the molecular masses of the unknown proteins were interpolated.
Partial purification of EAL. B. anthracis V770-NP-1R cells (pXO1+, pXO2-) grown in R medium were harvested by centrifugation at 104 x g for 15 min and suspended at 0.1 g/ml in 0.1 M acetate buffer-1.25 mM MgSO4 (pH 5.0), and DNase and RNase (Sigma) were added to 1 ,ug/ml. Following the passage of ice-cold cells through a French pressure cell (SLM Instruments, Inc., Urbana, Ill.) at 32,000 lb/in2, the disrupted cell suspension was centrifuged at 104 x g. The pellet was washed 3 times in ice cold 10 mM HEPES-2 mM MgSO4 (pH 7.5) at approximately 0.1 g/ml, followed by three washes with HEPES-MgSO4 buffer containing 0.1 M NaCl (pH 7.5). Microscopic examination of the material that was stained with crystal violet revealed an absence of intact cells. A portion of the particulate matter was suspended at 0.05 g/ml in PBS and sterilized with gamma irradiation (3 x 106 rads) while it was held on ice. Sterility checks were performed by plating 0.1 ml of the suspension on blood agar in triplicate and incubating for 2 days at 37°C. The sterile material was designated as irradiated cell wall and was stored at -20°C for later use in vaccine trials. The remainder of the particulate matter (approximately 100 g [wet weight]) was suspended to 0.1 g/ml in 2 M guanidine hydrochloride (containing 10 mM Tris, 10 mM EDTA, 10 ,ug of phenylmethylsulfonyl fluoride per ml, 0.02% sodium azide [pH 8.5]) and stirred slowly for 2 h at room temperature. The extracted insoluble particulate matter was removed by centrifugation, and the guanidine-soluble material was precipitated with 10 volumes of ice-cold methanol. The precipitate was dissolved in 2 M guanidine and filter sterilized, and precipitation with methanol was repeated. The precipitate, which was designated guanidine extract, was washed 2 times with 1 volume of distilled water and lyophilized. Electrophoretic analysis revealed that the material was essentially pure EAl (data not shown).
Polysaccharide-peptidoglycan complex preparation. The insoluble particulate matter described above was suspended to 0.25 g/ml in 1% SDS, heated to 90°C for 5 min, and centrifuged for 10 min at 27,000 x g. The supernatant was discarded, and extraction of the upper white portion of the pellet was repeated 2 times with hot 1% SDS and 4 times with distilled water at 90°C, followed by lyophilization.
Amino acid and amino sugar composition was determined on samples (1 mg/ml) that were hydrolyzed with 6 N HCl under nitrogen gas for 20 h at 100°C. The (Fig. 3) and B. anthracis Ames, New Hampshire, Colorado, and V770-NP-1R (data not shown).
The protective antigen was detected in the cell extracts ( Fig. 2 and 3) , thereby supporting the observations by Puziss and Howard (23) that PA could be extracted from whole cells. Animals vaccinated with the MDPH human vaccine had two-to fourfold higher titers to PA than did the animals vaccinated with B. anthracis Sterne (Anvax) ( Table 1) . This is consistent with the results of the electrophoretic immunotransblot (EITB) analyses, in that the relative intensities of PA staining by the sera from the Sterne strain-vaccinated animals were diminished as compared with those by the sera from MDPH-vaccinated animals (the identifying numbers for the sera shown in Table 1 correspond to the sera numbers in Fig. 2 and 3) . Except where indicated, the results of EITB analyses of sera given in Fig. 2 and 3 were obtained from animals 2 weeks after vaccination. Based on the relative intensities of the bands, it appeared that EAl rather than PA was initially the principal cell-associated antigen recognized by the Steme strain-vaccinated animals. However, in guinea pigs that were vaccinated with the MDPH human vaccine, PA was the primary antigen that was recognized, as was also the case with antisera from MDPH-vaccinated humans (Fig.  3, lanes 1 and 2) . EAl did not appear to be a major component of the culture supernatant, but nevertheless, it was clearly present (Fig. 3B, lanes 7 and 8; see also Fig. 2B ).
The PA protein in whole-cell extracts gave rise to several Fig. 2 . The sera were from animals vaccinated with either the Sterne strain live spore vaccine (strips 6 to 10) or the MDPH human vaccine (strips 11 to 16). Strips 3 to 5 were incubated with sera from control animals that were given saline injections. Strips 1 and 2 were reacted with sera from two human subjects that had been vaccinated with 0.5 ml of the MDPH vaccine (three biweekly injections with booster vaccinations at 6 and 12 months). Breakdown products of LF (protein A) and PA (protein B) are indicated. EA2 -mmlower-molecular-weight entities, including those identified by the letters B and C in Fig. 2B , strips 2 and 4, which may be breakdown products that resulted from protease activity (35) . These breakdown products reacted with MAb to PA (MAbs PA3-1F2-1-1 and PA2-2111-8C8-1-1; from S. Little, U.S. Army Medical Research Institute of Infectious Diseases), while another major band, labeled with the letter A ( Fig. 2B and 3 ), was weakly stained by MAbs to LF (LFII-7E-6-2-1) and EF (EFII-SC-10) (data not shown). As shown in Fig. 4 , strips 5 and 6, MAbs to EF, diluted 1:5 and 1:50, respectively, stained a protein that was slightly larger than PA but that was distinct from EAl and EA2. In Fig. 4 , strips 7 and 8 were stained with two MAbs to LF and strips 9 and 10 were stained with two MAbs to PA (diluted 1:50). In all cases, the toxin proteins were distinguishable from the EA proteins. Sera from guinea pigs that had been boosted with the   FIG. 4 . EITB analysis of Sterne cell-extracted proteins with sera from guinea pigs vaccinated with the Sterne strain (Anvax) (strips 1 and 2) and MDPH (strips 3 and 4). Strips 5 and 6 were reacted with the MAb to EF (MAb EFIII-9F5-1-1; tissue culture fluid) diluted 1:5 and 1:50, respectively. Two different MAb ascites fluid preparations specific for LF (MAb LFIII-2B2-1-2 and LFII-3E3-3-1) were used to stain strips 7 and 8, respectively. MAb preparations to PA (MAbs PAI-3B6-1-1 and PAI-2D3-3-1) were used to stain strips 9 and 10, respectively. The ascites fluid samples were diluted 1:50. Sterne strain vaccine 12 weeks after the initial three-vaccination series recognized an additional extractable antigen, EA2 (62 KDa) ( Fig. 1 and 4) , which had not been well recognized by sera collected at 2 weeks ( Fig. 2A and 3A) . The EA2 protein was detected only in B. anthracis strains that carried the pXO1 toxin plasmid, whereas EAl was detected in both plasmid-carrying and -cured strains (Table  2) .
Vaccine trials with EAL. Five groups of guinea pigs with 10 animals in each group were vaccinated with cell wall fragments sterilized by gamma irradiation, partially purified EAl (guanidine extract), viable Sterne strain spores (Anvax), MDPH human vaccine, or PBS (control). Guinea pigs vaccinated with cell wall fragments, EA1, or the Sterne strain produced antibody to EAl (Fig. 5) . The highest titers were in the group that received the cell wall (Table 3) . Although there appeared to be some staining of the EAl band when sera from the MDPH-vaccinated group were used (Fig. 5) , the mean titer was very low. As predicted, animals injected with cell wall had high titers to polysaccharide, as determined by ELISA and microagglutination. The polysaccharide of B. anthracis contains high levels of galactose and N-acetylglucosamine (3, 20) and is covalently linked to cell wall peptidoglycan (R. J. Doyle, personal communication). The complexes exhibited the following amino acid and amino sugar compositions which were indicative of peptidoglycan and polysaccharide: glutamic acid (6.9%; wt/wt), alanine (6.8%), m-diaminopemilic acid (8.9%), N-acetylglucosamine (29.7%), muramic acid (9.1%), and galactose (24.3%). The material was essentially free of other amino acids, thereby indicating an absence of protein. There was a strong correlation between the titers determined by microagglutination and those determined by the polysaccharide ELISA ( Table 3 ). The titer obtained with Bacillus cereus ATCC 9680 peptidoglycan material ranged from 1:8 and 1:16 in the animals that received irradiated cell wall, which suggests that the microagglutination titers presented in Table  3 are primarily against the polysaccharide portion of the complexes. Antibodies to PA and LF were very low in animals that received either cell wall or EA1, but were present in a high titer in Sterne strain-vaccinated animals. Guinea pigs that received the MDPH vaccine had the highest titers to PA, but produced relatively low titers to LF. strain or MDPH. The Sterne strain-and MDPH-vaccinated animals were completely protected, whereas the cell walland EAl-vaccinated animals were neither protected nor was their mean time to death extended (Table 3) . Indirect fluorescent antibody assays. Sera from animals used in the vaccine trial were tested by the indirect fluorescent antibody test on nonencapsulated Ames strain cells grown on blood agar and compared with the staining characteristics of encapsulated Ames cells obtained from bacteremic, terminally ill guinea pigs. Ames strain cells grown on blood agar were stained with sera from guinea pigs vaccinated with B. anthracis Sterne and guanidine extract in a manner characterized as intense patches or uniformly stained (data not shown). However, sera from animals vaccinated with irradiated cell wall, which had high titers not only to EAl but also to polysaccharide, uniformly stained the vegetative cells. Interestingly, cells which became detached from the slides left EAl on the slides in such a manner as to produce a ghost image of the cells when they were stained. In current studies with mouse MAb to EAl (data not shown), we have shown that Ames strain cells from blood agar cultures are stained in a manner identical to that of sera from guinea pigs vaccinated with the guanidine extract. The EAl MAbs also intensely stained the residue that was left on the slides following cell detachment, thereby providing additional evidence that EAl is a surface antigen of nonencapsulated cells. Sera from animals vaccinated with irradiated cell wall and guanidine extract stained the ends and septa of Ames strain cells that were obtained from bacteremic guinea pig blood, but did not stain the surface of the capsule (Fig. 6A ). This staining pattern was also noted with the MAb to EAl (data not shown). As stated above, sera from cell wall-vaccinated animals uniformly stained nonencapsulated Ames and Sterne strain cells grown on blood agar. This staining pattern was probably due in part to the high antibody titers to polysaccharide, since MAbs to polysaccharide (currently under study) stain in an identical manner. These data are consistent with reports that the galactose-containing polysaccharide is present on the surface of B. anthracis cells grown on blood agar and readily binds galactose-specific lectins (4). As for Sterne strainvaccinated animals, their sera stained the surface of the capsule and the septa ( Fig. 6B ; magnification is the same as that for Fig. 6A ) of Ames cells that were obtained from infected blood. This suggests that antibody to a noncapsular antigen(s) of the Ames cells, other than EAl or polysaccharide, is elicited by the Sterne strain cells in the Anvax vaccine. We propose that the lack of protection in animals which possess high titers to EAl and polysaccharide may in part be a result of the fact that these antigens are masked by the capsule of virulent strains in infected animals.
Demonstration of the fact that high antibody titers to two major surface antigens of the Sterne strain vaccine neither afford protection nor extend the time to death supports the premise that antibody to PA plays a central role in protection Alternative explanations for the differences in protection afforded by the two vaccines must be explored. For example, the presentation of PA to the immune system of the host by live spore vaccines may elicit an immune response (i.e., cell-mediated immunity) that is not obtained with aluminum hydroxide-adsorbed vaccines. Alternatively, crucial epitopes on the PA molecule, which are expressed on the PA released by live vaccines, may be either destroyed or masked when bound to aluminum hydroxide.
